MULTIPLE SYSTEM ATROPHY, MSA
Clinical trials for MULTIPLE SYSTEM ATROPHY, MSA explained in plain language.
Never miss a new study
Get alerted when new MULTIPLE SYSTEM ATROPHY, MSA trials appear
Sign up with your email to follow new studies for MULTIPLE SYSTEM ATROPHY, MSA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for MSA: can MSA-01 slow this rare brain disease?
Disease control Recruiting nowThis study tests a new drug called MSA-01 to see if it can slow the worsening of multiple system atrophy (MSA), a rare and serious brain disease. About 140 people with MSA who can still walk will get either MSA-01 or a placebo for 12 months. Researchers will measure changes in mo…
Matched conditions: MULTIPLE SYSTEM ATROPHY, MSA
Phase: PHASE3 • Sponsor: Tokyo University • Aim: Disease control
Last updated May 12, 2026 13:43 UTC
-
New PET tracer aims to spot Parkinson's protein in living brains
Diagnosis Recruiting nowThis early-phase study tests whether a new radioactive tracer called [18F]ACI-15916 can safely and reliably detect harmful alpha-synuclein protein clumps in the brain using PET scans. About 46 people—including healthy volunteers and those with suspected Parkinson's disease, multi…
Matched conditions: MULTIPLE SYSTEM ATROPHY, MSA
Phase: EARLY_PHASE1 • Sponsor: AC Immune SA • Aim: Diagnosis
Last updated May 11, 2026 20:52 UTC
-
New drug aleeto tested for rare brain disease
Symptom relief Recruiting nowThis early-stage study tests the safety of a new drug, Aleeto, in 20 people with Multiple System Atrophy (MSA), a rare brain disease that affects movement and body functions. Participants will be randomly assigned to receive Aleeto or standard care, and researchers will monitor s…
Matched conditions: MULTIPLE SYSTEM ATROPHY, MSA
Phase: EARLY_PHASE1 • Sponsor: Beijing Tiantan Hospital • Aim: Symptom relief
Last updated May 17, 2026 05:08 UTC